ProMIS Neurosciences, Inc.
PMN
$9.75
$0.040.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 227.87% | 162.41% | 167.87% | 119.74% | 31.05% |
| Gross Profit | -227.87% | -162.41% | -167.87% | -119.74% | -31.05% |
| SG&A Expenses | -2.51% | 9.67% | 14.61% | 23.18% | 2.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 100.63% | 138.70% | 140.80% | 119.69% | 58.93% |
| Operating Income | -100.63% | -138.70% | -140.80% | -119.69% | -58.93% |
| Income Before Tax | -4,248.57% | -1,529.36% | -5,097.59% | 30.92% | 92.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4,248.57% | -1,529.36% | -5,097.59% | 30.92% | 92.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4,248.57% | -1,529.36% | -5,097.59% | 30.92% | 92.14% |
| EBIT | -100.63% | -138.70% | -140.80% | -119.69% | -58.93% |
| EBITDA | -- | -- | 59.11% | 18.25% | -1.48% |
| EPS Basic | -1,694.84% | -5,317.67% | -286.76% | 71.26% | 95.00% |
| Normalized Basic EPS | -1,358.48% | -1,178.27% | -234.57% | 85.77% | 107.13% |
| EPS Diluted | -1,639.01% | -4,867.83% | -289.08% | 71.03% | 94.81% |
| Normalized Diluted EPS | -1,367.96% | -1,183.98% | -233.81% | 85.71% | 107.07% |
| Average Basic Shares Outstanding | 160.61% | 75.70% | 72.48% | 88.80% | 98.87% |
| Average Diluted Shares Outstanding | 160.51% | 75.62% | 72.39% | 88.86% | 98.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |